Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the patent expiry of ...

"When Wegovy and high-dose semaglutide were approved in 2021, that's when we started seeing around 15% total body weight loss ...

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

Five University of Cambridge experts have shared their views on whether semaglutide-based drugs like Wegovy and Ozempic can ...

Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.

According to a new study published in the journal Alzheimer's & Dementia, Semaglutide, the active ingredient in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease in people with Type 2 ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...